| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT)
EYPT Technical Analysis
4
| As on 9th Jun 2023 EYPT STOCK Price closed @ 6.05 and we RECOMMEND Sell for LONG-TERM with Stoploss of 9.40 & Strong Sell for SHORT-TERM with Stoploss of 10.78 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EYPTSTOCK Price
| Open | 6.09 | Change | Price | % |
| High | 6.26 | 1 Day | -0.03 | -0.49 |
| Low | 5.92 | 1 Week | 0.00 | 0.00 |
| Close | 6.05 | 1 Month | -0.22 | -3.51 |
| Volume | 271960 | 1 Year | -7.61 | -55.71 |
| 52 Week High 14.11 | 52 Week Low 2.28 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| EYPT Daily Charts |
EYPT Intraday Charts |
Whats New @ Bazaartrend |
EYPT Free Analysis |
|
|
EYPT Important Levels Intraday
| RESISTANCE | 6.71 |
| RESISTANCE | 6.50 |
| RESISTANCE | 6.37 |
| RESISTANCE | 6.24 |
| SUPPORT | 5.86 |
| SUPPORT | 5.73 |
| SUPPORT | 5.60 |
| SUPPORT | 5.39 |
EYPT Forecast May 2024
| 4th UP Forecast | 17.4 |
| 3rd UP Forecast | 13.76 |
| 2nd UP Forecast | 11.51 |
| 1st UP Forecast | 9.26 |
| 1st DOWN Forecast | 2.84 |
| 2nd DOWN Forecast | 0.59 |
| 3rd DOWN Forecast | -1.66 |
| 4th DOWN Forecast | -5.3 |
EYPT Weekly Forecast
| 4th UP Forecast | 9.60 |
| 3rd UP Forecast | 8.46 |
| 2nd UP Forecast | 7.76 |
| 1st UP Forecast | 7.05 |
| 1st DOWN Forecast | 5.05 |
| 2nd DOWN Forecast | 4.34 |
| 3rd DOWN Forecast | 3.64 |
| 4th DOWN Forecast | 2.50 |
EYPT Forecast2024
| 4th UP Forecast | 29.6 |
| 3rd UP Forecast | 22.05 |
| 2nd UP Forecast | 17.38 |
| 1st UP Forecast | 12.71 |
| 1st DOWN Forecast | -0.61 |
| 2nd DOWN Forecast | -5.28 |
| 3rd DOWN Forecast | -9.95 |
| 4th DOWN Forecast | -17.5 |
EyePoint Pharmaceuticals Inc ( NASDAQ USA Symbol : EYPT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EYPT Business Profile
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye; and DEXYCU, a dexamethasone intraocular suspension, for the treatment of post-operative ocular inflammation, including treatment following cataract surgery. It is also developing EYP-1901, a twice-yearly bioerodible formulation of tyrosine kinase inhibitor that is in Phase 1 clinical trials for the treatment of wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion; and YUTIQ50 for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The company has strategic collaborations with Alimera Sciences, Inc., Bausch & Lomb, OncoSil Medical UK Limited, Ocumension Therapeutics, and Equinox Science, LLC. It also has a commercial alliance with ImprimisRx PA, Inc. for the joint promotion of DEXYCU for the treatment of post-operative inflammation following ocular surgery. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts. Address: 480 Pleasant Street, Watertown, MA, United States, 02472
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service